Owkin
Agathe Arlotti is a seasoned professional in the health and nutrition sectors, currently serving as SVP of Partnerships at Owkin since July 2021. Previously, Agathe led a team at Medicen Paris Region focused on healthtech innovations, securing significant public funding for numerous projects. Agathe has also held leadership roles in technology transfer and partnership development at CRCHUM and has extensive experience in managing research projects related to obesity and microbiota at ICAN Institute. Early career roles include research leadership at Mondelēz International and Nestlé, where Agathe contributed to product innovation and regulatory compliance. Educational qualifications include an engineering degree from AgroParisTech and additional studies at McGill University and PMI Montreal, emphasizing expertise in clinical research practices.
This person is not in any offices
Owkin
6 followers
Owkin believes that medical research should be collaborative, inclusive, and privacy-preserving. Today, Owkin is pioneering AI in healthcare. It leverages its collaborative federated learning software and expert AI capabilities to bring solutions to optimize drug development and improve patient care in oncology. Owkin’s work has been published in Nature Medicine and other top-tier journals. Owkin has raised over $70M from leading VC funds and is now working with the most prominent cancer centers and pharmaceutical companies in Europe and the US. Additionally, Owkin leads several federated learning consortia, including; MELLODDY, to facilitate 'co-opetive' drug discovery between pharma companies, and Healthchain, to allow collaborative research across multiple hospitals. Owkin was co-founded in 2016 by Thomas Clozel, MD, a clinical research doctor and former assistant professor in clinical hematology, and by Gilles Wainrib, Ph.D., an academic pioneer in the field of Artificial Intelligence in biology.